{"id":"NCT02084069","sponsor":"Urmia University of Medical Sciences","briefTitle":"Atrovastatin for Preventing Atrial Fibrillation Following Open Cardiac Valve Repair","officialTitle":null,"status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-01","primaryCompletion":"2014-04","completion":"2014-04","firstPosted":"2014-03-11","resultsPosted":"2015-02-04","lastUpdate":"2015-03-04"},"enrollment":58,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"PREVENTION"},"conditions":["Heart Valve Diseases"],"interventions":[{"type":"DRUG","name":"Atorvastatin","otherNames":[]}],"arms":[{"label":"Treatment","type":"ACTIVE_COMPARATOR"},{"label":"Control","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of the investigation is to determine whether Atrovastatin as anti-inflammatory agent can be effective in preventing from atrial fibrillation incidence in patients whom undergone open cardiac surgery for their heart valve repair.","primaryOutcome":{"measure":"Atrial Fibrillation Incidence After Open Cardiac Valve Repair","timeFrame":"Within 5 days after open cardiac valve repair","effectByArm":[{"arm":"Treatment","deltaMin":6,"sd":null},{"arm":"Control","deltaMin":13,"sd":null}],"pValues":[]},"eligibility":{"minAge":"25 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":12},"locations":{"siteCount":1,"countries":["Iran"]},"refs":{"pmids":["25540059"],"seeAlso":["http://umsu.ac.ir"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":29},"commonTop":[]}}